Myofascial pain syndrome. Chronic pain syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 20 to 45 years Presence of primary pain in the calf muscles Initial pain intensity between 3 and 8 on the Numeric Pain Rating Scale (NPRS) during initial assessment Presence of an active trigger point in the lateral head of the gastrocnemius muscle on the affected side Individuals with a BMI between 18 and 27
Exclusion criteria
Exclusion criteria: History of recent surgery in the lower limb History of trauma in recent years Physiotherapy treatment within the past six months Presence of cardiovascular diseases or thrombosis Diabetes mellitus and hypertension Fibromyalgia syndrome, diagnosed by a specialist physician and confirmed by the therapist through palpation of the related tender points Skin injury, infection, or inflammatory edema at the site of the trigger point at the time of testing Pregnancy at the time of testing Use of sedative or anticoagulant medications before or during the treatment Needle phobia Possibility of any systemic inflammation (due to malignancy, common cold, infection, or any other condition associated with inflammatory factors in the blood)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle sorness. Timepoint: Immediately after, 48 hours and one week after receiving the intervention. Method of measurement: The Numerical Pain Rating Scale, as well as measurements of blood inflammatory factors, used to determine muscle soreness caused by the needle. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain pressure treshold. Timepoint: Before, immediately after, 48 hours and one week after receiving the intervention. Method of measurement: In this study, an algometer was used to press on a trigger point located on the lateral head of the gastrocnemius muscle, and the pressure at which the patient first reports a pain sensation was considered the pressure pain threshold.;Functional disability. Timepoint: Before and one week after receiving the intervention. Method of measurement: In this study, the Persian equivalent version of the Lower Extremity Functional Scale (LEFS) questionnaire was used to assess the level of lower extremity functional disability in the treatment groups.;Muscle blood flow. Timepoint: Before, immediately after, and 48 hours after receiving the intervention. Method of measurement: In this study, blood flow around the trigger point in the lateral head of the gastrocnemius muscle was calculated using a linear probe by measuring the maximum systolic velocity, minimum diastolic velocity, and vascular resistance index in the posterior tibial artery using a Doppler ultrasound device.;Muscle thickness. Timepoint: Before the intervention, immediately after and 48 hours later. Method of measurement: In this study, a B-Mode image is taken of the muscle at rest and contraction states using an ultrasound device and a linear probe. The probe is placed on the lateral gastrocnemius muscle and parallel to the muscle fibers. The maximum horizontal distance between the two hyperechoic fasciae on both sides of the muscle is recorded as the muscle thickness.;Blood inflammatory factors. Timepoint: The first sample is collected before the intervention and the second sample is collected 48 hours after the intervention. Method of measurement: To assess gastrocnemius muscle tissue irritation after dry needling, serum C-reactive protein and creatine kinase levels are measured through a blood test.;Dorsiflexion range of motion. Timepoint: Before, immediately after, 48 | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences